<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04601103</url>
  </required_header>
  <id_info>
    <org_study_id>EM-11-050043</org_study_id>
    <nct_id>NCT04601103</nct_id>
  </id_info>
  <brief_title>3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes</brief_title>
  <official_title>3M Oral Rinse Evaluation of Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>3M</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>3M</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the incidence of oral tissue sloughing&#xD;
      through self-report by study subjects and by professional dental examinations.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to evaluate the incidence of oral tissue sloughing&#xD;
      through self-report by study subjects and by professional dental examinations. Adverse events&#xD;
      will be tracked through study dental examinations and subject diaries with twice daily use of&#xD;
      the 3M Oral Rinse used in combination with toothpaste containing one of three levels (no,&#xD;
      medium, high) of Sodium Lauryl Sulfate (SLS).&#xD;
&#xD;
      Determine the subjects' acceptance of sloughing and/or other side effects&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Device Deficiency&#xD;
  </why_stopped>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Actual">March 10, 2020</completion_date>
  <primary_completion_date type="Actual">March 10, 2020</primary_completion_date>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study was designed as an imbalanced 2 Period Crossover Study. However, the study was terminated during the washout period and the results reported here reflect only the period 1 results.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Assessors did not know what toothpaste subjects used.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With a Reported Oral Mucosal Exfoliation Adverse Event (Oral Sloughing Incidence)</measure>
    <time_frame>End of treatment (3 weeks)</time_frame>
    <description>Evaluation of incidence rate of oral sloughing as assessed by the subject and/or assessor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores</measure>
    <time_frame>Mid-Treatment (10 days)</time_frame>
    <description>Average score based on the mean of sloughing scores over 12 intra-oral areas. The sloughing score uses a 6 point scale as follows: 0= no sloughing, 1=flecks of desquamation, 2=sheets of desquamation, 3=redness, not due to plaque, 4=erosion of mucosa, 5=ulcerated areas.&#xD;
The twelve intra-oral areas of the mouth are as follows: dorsal and ventral surfaces of the tongue, floor and roof of the mouth, right and left buccal mucosa, gingival tissue.&#xD;
(upper right, upper anterior, upper left, lower left, lower anterior, lower right)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores.</measure>
    <time_frame>End of Treatment (3 weeks)</time_frame>
    <description>Average score based on the mean of sloughing scores over 12 intra-oral areas. The sloughing score uses a 6 point scale as follows: 0= no sloughing, 1=flecks of desquamation, 2=sheets of desquamation, 3=redness, not due to plaque, 4=erosion of mucosa, 5=ulcerated areas.&#xD;
The twelve intra-oral areas of the mouth are as follows: dorsal and ventral surfaces of the tongue, floor and roof of the mouth, right and left buccal mucosa, gingival tissue.&#xD;
(upper right, upper anterior, upper left, lower left, lower anterior, lower right)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The Number of Participants Reporting Their Acceptance Levels of Side Effects</measure>
    <time_frame>End of Treatment (3 weeks)</time_frame>
    <description>Subjects were questioned regarding how acceptable were your side effects. Using the following responses of: Completely unacceptable, somewhat unacceptable, somewhat acceptable, completely acceptable, did not experience side effects</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Oral Mucosal Disorder</condition>
  <arm_group>
    <arm_group_label>Comparator: No SLS Toothpaste</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3M Oral Rinse in combination with no SLS toothpaste (A)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator: Medium SLS Toothpaste</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3M Oral Rinse in combination with medium SLS toothpaste (B)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator: High SLS Toothpaste</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3M Oral Rinse in combination with high SLS toothpaste (C)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>No SLS toothpaste</intervention_name>
    <description>Toothpaste no Sodium Lauryl Sulfate</description>
    <arm_group_label>Comparator: No SLS Toothpaste</arm_group_label>
    <other_name>Sensodyne ProNamel Fresh Breath Toothpaste</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Medium SLS toothpaste</intervention_name>
    <description>Less than or equal to X ppm Sodium Lauryl Sulfate</description>
    <arm_group_label>Comparator: Medium SLS Toothpaste</arm_group_label>
    <other_name>Clinpro Tooth Creme</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High SLS toothpaste</intervention_name>
    <description>More than or equal to X ppm Sodium Lauryl Sulfate</description>
    <arm_group_label>Comparator: High SLS Toothpaste</arm_group_label>
    <other_name>Colgate Cavity Protection Toothpaste</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anti-plaque</intervention_name>
    <description>Rinse prevents bacterial adherence to teeth</description>
    <arm_group_label>Comparator: High SLS Toothpaste</arm_group_label>
    <arm_group_label>Comparator: Medium SLS Toothpaste</arm_group_label>
    <arm_group_label>Comparator: No SLS Toothpaste</arm_group_label>
    <other_name>3M Oral Rinse</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          1. Able to understand and willing to sign the informed consent;&#xD;
&#xD;
          2. Willing to agree to maintain confidentiality of the study and study materials;&#xD;
&#xD;
          3. 3M employee aged 18 years and older;&#xD;
&#xD;
          4. Willing to return to the study facility for scheduled study visits and recalls;&#xD;
&#xD;
          5. Agree not to use other oral hygiene products (non-study toothpaste, non-study&#xD;
             toothbrush, mouth rinse, chewing gum);&#xD;
&#xD;
          6. Agree to the study instruction and schedule&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
          7. A member of the Medical Clinical Affairs (MCA) staff or Panda product team for the&#xD;
             device under investigation;&#xD;
&#xD;
          8. Have a dental appointment scheduled during study duration for professional cleaning;&#xD;
&#xD;
          9. Is pregnant, nursing, or planning to become pregnant within the study duration;&#xD;
&#xD;
         10. History of antibiotic therapy within the previous 30 days or have a condition that is&#xD;
             likely to need antibiotic treatment over the course of the study (e.g., cardiac&#xD;
             conditions requiring antibiotic prophylaxis such as heart murmurs, pacemakers, or&#xD;
             prosthetic heart valves and prosthetic implants);&#xD;
&#xD;
         11. History of using a prescription antimicrobial mouth rinse during the past 3 months;&#xD;
&#xD;
         12. Currently taking medications which may alter gingival appearance/bleeding;&#xD;
&#xD;
         13. Currently using anticonvulsants, calcium channel blockers, or other medications with&#xD;
             side effects known to impact oral health;&#xD;
&#xD;
         14. Participation in any other clinical study within the last 30 days;&#xD;
&#xD;
         15. Resides in the same household with a subject already enrolled in the study;&#xD;
&#xD;
         16. Known history of sensitivity to oral hygiene products;&#xD;
&#xD;
         17. Currently using tobacco products (cigarettes, chewing tobacco) or vaping products&#xD;
             (ecigarettes);&#xD;
&#xD;
         18. History of diabetes;&#xD;
&#xD;
         19. Have removable partial/full dentures;&#xD;
&#xD;
         20. Have orthodontic appliances;&#xD;
&#xD;
         21. Have medical or oral conditions that may compromise the subject's safety or interfere&#xD;
             with the conduct and outcome of the study;&#xD;
&#xD;
         22. Have known sloughing within the last 3 weeks;&#xD;
&#xD;
         23. Have dry mouth;&#xD;
&#xD;
         24. Have widespread caries or chronic neglect;&#xD;
&#xD;
         25. Have gross pathological changes of oral soft tissues;&#xD;
&#xD;
         26. Have advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive&#xD;
             alveolar bone loss);&#xD;
&#xD;
         27. Unsuitable for enrollment in this study based on the professional opinion of the&#xD;
             dental examiner based on the oral exam or other reasons not specified in the protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>3M Health Care</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 13, 2020</study_first_submitted>
  <study_first_submitted_qc>October 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2020</study_first_posted>
  <results_first_submitted>September 16, 2021</results_first_submitted>
  <results_first_submitted_qc>October 25, 2021</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 19, 2021</results_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 7, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/03/NCT04601103/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Comparator: No SLS Toothpaste</title>
          <description>3M Oral Rinse in combination with no SLS toothpaste (A)&#xD;
No SLS toothpaste: Toothpaste no Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
        </group>
        <group group_id="P2">
          <title>Comparator: Medium SLS Toothpaste</title>
          <description>3M Oral Rinse in combination with medium SLS toothpaste (B)&#xD;
Medium SLS toothpaste: Less than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
        </group>
        <group group_id="P3">
          <title>Comparator: High SLS Toothpaste</title>
          <description>3M Oral Rinse in combination with high SLS toothpaste (C)&#xD;
High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Needed crown &amp; cleaning</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>study was terminated</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Comparator: No SLS Toothpaste</title>
          <description>3M Oral Rinse in combination with no SLS toothpaste (A)&#xD;
No SLS toothpaste: Toothpaste no Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
        </group>
        <group group_id="B2">
          <title>Comparator: Medium SLS Toothpaste</title>
          <description>3M Oral Rinse in combination with medium SLS toothpaste (B)&#xD;
Medium SLS toothpaste: Less than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
        </group>
        <group group_id="B3">
          <title>Comparator: High SLS Toothpaste</title>
          <description>3M Oral Rinse in combination with high SLS toothpaste (C)&#xD;
High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="18"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="17"/>
            <count group_id="B4" value="53"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.2" spread="10.3"/>
                    <measurement group_id="B2" value="39.7" spread="12.09"/>
                    <measurement group_id="B3" value="38.5" spread="11.82"/>
                    <measurement group_id="B4" value="40.5" spread="11.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With a Reported Oral Mucosal Exfoliation Adverse Event (Oral Sloughing Incidence)</title>
        <description>Evaluation of incidence rate of oral sloughing as assessed by the subject and/or assessor</description>
        <time_frame>End of treatment (3 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comparator: No SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with no SLS toothpaste (A)&#xD;
No SLS toothpaste: Toothpaste no Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
          <group group_id="O2">
            <title>Comparator: Medium SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with medium SLS toothpaste (B)&#xD;
Medium SLS toothpaste: Less than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
          <group group_id="O3">
            <title>Comparator: High SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with high SLS toothpaste (C)&#xD;
High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Reported Oral Mucosal Exfoliation Adverse Event (Oral Sloughing Incidence)</title>
          <description>Evaluation of incidence rate of oral sloughing as assessed by the subject and/or assessor</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Generalized Fisher's Exact Test was used to detect an association between the 3 treatment groups and the incidence of sloughing</non_inferiority_desc>
            <p_value>.916</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores</title>
        <description>Average score based on the mean of sloughing scores over 12 intra-oral areas. The sloughing score uses a 6 point scale as follows: 0= no sloughing, 1=flecks of desquamation, 2=sheets of desquamation, 3=redness, not due to plaque, 4=erosion of mucosa, 5=ulcerated areas.&#xD;
The twelve intra-oral areas of the mouth are as follows: dorsal and ventral surfaces of the tongue, floor and roof of the mouth, right and left buccal mucosa, gingival tissue.&#xD;
(upper right, upper anterior, upper left, lower left, lower anterior, lower right)</description>
        <time_frame>Mid-Treatment (10 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comparator: No SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with no SLS toothpaste (A)&#xD;
No SLS toothpaste: Toothpaste no Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
          <group group_id="O2">
            <title>Comparator: Medium SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with medium SLS toothpaste (B)&#xD;
Medium SLS toothpaste: Less than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
          <group group_id="O3">
            <title>Comparator: High SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with high SLS toothpaste (C)&#xD;
High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
        </group_list>
        <measure>
          <title>The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores</title>
          <description>Average score based on the mean of sloughing scores over 12 intra-oral areas. The sloughing score uses a 6 point scale as follows: 0= no sloughing, 1=flecks of desquamation, 2=sheets of desquamation, 3=redness, not due to plaque, 4=erosion of mucosa, 5=ulcerated areas.&#xD;
The twelve intra-oral areas of the mouth are as follows: dorsal and ventral surfaces of the tongue, floor and roof of the mouth, right and left buccal mucosa, gingival tissue.&#xD;
(upper right, upper anterior, upper left, lower left, lower anterior, lower right)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>0 no sloughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>(0.0, 0.5]</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>(0.5, 1.0]</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>(1.0, 1.5]</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>(1.5, 2.0]</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores.</title>
        <description>Average score based on the mean of sloughing scores over 12 intra-oral areas. The sloughing score uses a 6 point scale as follows: 0= no sloughing, 1=flecks of desquamation, 2=sheets of desquamation, 3=redness, not due to plaque, 4=erosion of mucosa, 5=ulcerated areas.&#xD;
The twelve intra-oral areas of the mouth are as follows: dorsal and ventral surfaces of the tongue, floor and roof of the mouth, right and left buccal mucosa, gingival tissue.&#xD;
(upper right, upper anterior, upper left, lower left, lower anterior, lower right)</description>
        <time_frame>End of Treatment (3 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comparator: No SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with no SLS toothpaste (A)&#xD;
No SLS toothpaste: Toothpaste no Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
          <group group_id="O2">
            <title>Comparator: Medium SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with medium SLS toothpaste (B)&#xD;
Medium SLS toothpaste: Less than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
          <group group_id="O3">
            <title>Comparator: High SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with high SLS toothpaste (C)&#xD;
High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
        </group_list>
        <measure>
          <title>The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores.</title>
          <description>Average score based on the mean of sloughing scores over 12 intra-oral areas. The sloughing score uses a 6 point scale as follows: 0= no sloughing, 1=flecks of desquamation, 2=sheets of desquamation, 3=redness, not due to plaque, 4=erosion of mucosa, 5=ulcerated areas.&#xD;
The twelve intra-oral areas of the mouth are as follows: dorsal and ventral surfaces of the tongue, floor and roof of the mouth, right and left buccal mucosa, gingival tissue.&#xD;
(upper right, upper anterior, upper left, lower left, lower anterior, lower right)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>0 No sloughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>(0.0, 0.5]</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>(0.5, 1.0]</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>(1.0, 1.5]</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>The Number of Participants Reporting Their Acceptance Levels of Side Effects</title>
        <description>Subjects were questioned regarding how acceptable were your side effects. Using the following responses of: Completely unacceptable, somewhat unacceptable, somewhat acceptable, completely acceptable, did not experience side effects</description>
        <time_frame>End of Treatment (3 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comparator: No SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with no SLS toothpaste (A)&#xD;
No SLS toothpaste: Toothpaste no Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
          <group group_id="O2">
            <title>Comparator: Medium SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with medium SLS toothpaste (B)&#xD;
Medium SLS toothpaste: Less than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
          <group group_id="O3">
            <title>Comparator: High SLS Toothpaste</title>
            <description>3M Oral Rinse in combination with high SLS toothpaste (C)&#xD;
High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
          </group>
        </group_list>
        <measure>
          <title>The Number of Participants Reporting Their Acceptance Levels of Side Effects</title>
          <description>Subjects were questioned regarding how acceptable were your side effects. Using the following responses of: Completely unacceptable, somewhat unacceptable, somewhat acceptable, completely acceptable, did not experience side effects</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Completely unacceptable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat unacceptable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat acceptable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Completely acceptable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Did not experience side effects</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Within 3 weeks of starting treatment</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Comparator: No SLS Toothpaste</title>
          <description>3M Oral Rinse in combination with no SLS toothpaste (A)&#xD;
No SLS toothpaste: Toothpaste no Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
        </group>
        <group group_id="E2">
          <title>Comparator: Medium SLS Toothpaste</title>
          <description>3M Oral Rinse in combination with medium SLS toothpaste (B)&#xD;
Medium SLS toothpaste: Less than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
        </group>
        <group group_id="E3">
          <title>Comparator: High SLS Toothpaste</title>
          <description>3M Oral Rinse in combination with high SLS toothpaste (C)&#xD;
High SLS toothpaste: More than or equal to X ppm Sodium Lauryl Phosphate&#xD;
Anti-plaque: Rinse prevents bacterial adherence to teeth</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Aphthous ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Breath odor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Buccal mucosal roughening</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Glossitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia teeth</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia oral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Mouth injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Oral discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Oral mucosal exfoliation</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="18"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="18"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Oral pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Salivary hypersecretion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Sensitivity of teeth</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Tongue biting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Tongue exfoliation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The major limitation with this study is that the sample size goal was not reached given the early termination during the washout period of a two-period crossover design.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Brenda Coalwell, Clinical Affairs Manager</name_or_title>
      <organization>3M Health Care Business Group</organization>
      <phone>16517362456</phone>
      <email>bccoalwell1@mmm.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

